Dr. Ladenson on Diagnosis of Thyroid Nodules
Dr. Paul W. Ladenson, from Johns Hopkins Medicine, on Diagnosis of Thyroid Nodules
Carriers of Mutation Responsible for Multiple Endocrine Neoplasia Can Face Difficult Choices
Results of a multi-generational case study strengthen the case for genetic screening in cases of hereditary thyroid cancer.
Researchers Find Regional Differences in Stage of Presentation and Survival of Individuals With Thyroid Cancer
Patients are more likely to present with regional or distant metastases and experience lower rates of cancer-free survival depending on where they live.
Genetic Data Points to Potential New Therapeutic Target for Adrenocortical Carcinoma
Researchers find that overexpression of a specific gene is associated with poor survival in patients with adrenocortical carcinoma.
Why Medical Tattoos Shouldn't Be Taboo
Another presentation at the AACE meeting on Thursday featured Dr. Saleh Aldasouqi, FACE, ECNU, discussing a topic that is not heard about too often in the medical world: tattoos.
Telemedicine a Valuable Way to Deliver Healthcare
Patients who live far from medical facilities benefit from having "virtual" conversations with their doctors and are comfortable with that arrangement.
AACE 21st Annual Scientific and Clinical Congress Slideshow
Photos taken from the AACE 21st Annual Scientific and Clinical Congress held at the Pennsylvania Convention Center, from May 23-27, 2012.
Oncology Posters Presented at Annual Endocrinology Meeting
A look at two poster presentations from the AACE meeting focusing on insular carcinoma and medullary thyroid cancer.
Conference Coverage From AACE Coming Soon
Stay tuned for live coverage from the American Association of Clinical Endocrinologists (AACE) 21st Annual Scientific and Clinical Congress.
Sotigalimab/Pembrolizumab Combo Continues to Show Clinical Activity in Frontline Melanoma
Dr. Halmos on Trastuzumab Deruxtecan in NSCLC
Dr. Kris on Immunotherapy in NSCLC Without Driver Mutations
Checkpoint Inhibitor Challenges Warrant Consideration for a Targeted Approach in NSCLC
2 Clarke DriveSuite 100Cranbury, NJ 08512
© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.